Literature DB >> 29316280

Giant congenital melanocytic nevus with vascular malformation and epidermal cysts associated with a somatic activating mutation in BRAF.

Heather C Etchevers1, Christian Rose2, Birgit Kahle3, Helmuth Vorbringer4, Frédéric Fina5, Pauline Heux1, Irina Berger6, Benjamin Schwarz1, Stéphane Zaffran1, Nicolas Macagno5,7, Sven Krengel8.   

Abstract

Giant congenital melanocytic nevi may be symptomatically isolated or syndromic. Associations with capillary malformations are exceptional, and development of epidermal cysts has not been described. A 71-year-old patient with a giant congenital melanocytic nevus (CMN) of the lower back, buttocks, and thighs was asymptomatic except for unexpected hemorrhage during partial surgical excision years before. Blunt trauma at age 64 initiated recurrent, severe pain under the nevus; multiple large epidermal cysts then developed within it. Imaging and biopsy showed a large, non-pulsatile venous malformation intermingled with the deep nevus. A low-abundance, heterozygous BRAF c.1799T>A (p.V600E) mutation was present in both gluteal and occipital congenital nevi; additional mutations in NRAS, GNAQ, GNA11, HRAS, or PIK3CA were undetectable. This is the first demonstration of a recurrent BRAF mutation in multiple large congenital nevi from the same individual, confirming that this malformation can have multiple genetic origins. Early constitutive activation of BRAF can therefore cause unusual associations of giant nevi with vascular malformations, indicating that both pigment and endothelial cell physiology may be affected by mosaic RASopathies.
© 2018 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  braf; malformation; mosaic; neural crest; venous

Mesh:

Substances:

Year:  2018        PMID: 29316280     DOI: 10.1111/pcmr.12685

Source DB:  PubMed          Journal:  Pigment Cell Melanoma Res        ISSN: 1755-1471            Impact factor:   4.693


  3 in total

1.  Does the gene matter? Genotype-phenotype and genotype-outcome associations in congenital melanocytic naevi.

Authors:  S Polubothu; N McGuire; L Al-Olabi; W Baird; N Bulstrode; J Chalker; D Josifova; D Lomas; J O'Hara; J Ong; D Rampling; P Stadnik; A Thomas; E Wedgeworth; N J Sebire; V A Kinsler
Journal:  Br J Dermatol       Date:  2019-08-09       Impact factor: 9.302

2.  Novel genetic alteration in congenital melanocytic nevus: MAP2K1 germline mutation with BRAF somatic mutation.

Authors:  Yun Zou; Yi Sun; Xiaojing Zeng; Yun Liu; Qingqing Cen; Hao Gu; Xiaoxi Lin; Ren Cai; Hui Chen
Journal:  Hereditas       Date:  2020-08-26       Impact factor: 3.271

3.  Inherited duplications of PPP2R3B predispose to nevi and melanoma via a C21orf91-driven proliferative phenotype.

Authors:  Satyamaanasa Polubothu; Davide Zecchin; Lara Al-Olabi; Daniël A Lionarons; Mark Harland; Stuart Horswell; Anna C Thomas; Lilian Hunt; Nathan Wlodarchak; Paula Aguilera; Sarah Brand; Dale Bryant; Cristina Carrera; Hui Chen; Greg Elgar; Catherine A Harwood; Michael Howell; Lionel Larue; Sam Loughlin; Jeff MacDonald; Josep Malvehy; Sara Martin Barberan; Vanessa Martins da Silva; Miriam Molina; Deborah Morrogh; Dale Moulding; Jérémie Nsengimana; Alan Pittman; Joan-Anton Puig-Butillé; Kiran Parmar; Neil J Sebire; Stephen Scherer; Paulina Stadnik; Philip Stanier; Gemma Tell; Regula Waelchli; Mehdi Zarrei; Susana Puig; Véronique Bataille; Yongna Xing; Eugene Healy; Gudrun E Moore; Wei-Li Di; Julia Newton-Bishop; Julian Downward; Veronica A Kinsler
Journal:  Genet Med       Date:  2021-06-18       Impact factor: 8.822

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.